YIELD10 BIOSCIENCE, INC. (NASDAQ:YTEN) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02 Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.>
Yield10 Bioscience, Inc. (the Company) set the authorized size of
the Board at seven (7) members and appointed Richard Hamilton,
Ph.D. as a member of the Board, to serve in Class III of the
Board, with a term expiring at the 2018 Annual Meeting of
Shareholders. In connection with his appointment, Dr. Hamilton
was appointed to serve on the Audit and Compensation Committees
of the Board.
Officer of Ceres Inc. from September 2002 until Ceres acquisition
by Land OLakes, Inc. in August 2016. He served as Ceres Chief
Financial Officer from 1998 until September 2002, at which time
he was appointed President and Chief Executive Officer. He served
on Ceres Board of Directors from 2002 – 2016. In addition to his
leadership role at Ceres, Dr. Hamilton has sat on the Keck
Graduate Institute Advisory Council and he was a founding member
of the Council for Sustainable Biomass Production. He has served
on the U.S. Department of Energys Biomass Research and
Development Technical Advisory Committee and has been active in
the Biotechnology Industry Organization where he has served as
Vice Chairman of the organization, chaired its Food and
Agriculture Governing Board and served in other leadership roles.
From 1996 to 1998, Dr. Hamilton was a Principal at Oxford
Bioscience Partners, one of the leading investors in the genomics
field and a founder of Ceres. He was an Associate at Boston-based
MVP Ventures from 1993 to1996. From 1990 to 1992, he was a Howard
Hughes Medical Institute Research Fellow at Harvard Medical
School. Dr. Hamilton holds a Ph.D. in molecular biology from
Vanderbilt University and a B.S. in biology from St. Lawrence
University.
or any other person to which he was selected as a member of the
Board. The Company is not aware of any transaction in which Dr.
Hamilton has an interest requiring disclosure under Item 404(a)
of Regulation S-K.
receive compensation for his service as a member of the Board to
the Companys policy for compensation of non-employee directors.
Her resignation was not the result of any disagreement with the
Company relating to the Companys policies or practices.
Hamiltons appointment to the Board, is attached as Exhibit 99.1
to this Current Report.
|
Item 9.01.
|
Financial Statements and Exhibits.
|
|
(d)
|
Exhibits.
|
||
|
Exhibit No.
|
Description
|
||
|
99.1
|
Press Release
|
||
About YIELD10 BIOSCIENCE, INC. (NASDAQ:YTEN)
Yield10 Bioscience, Inc., formerly Metabolix, Inc., is an agricultural bioscience company. The Company is focused on developing disruptive technologies for step-change improvements in crop yield for food and feed crops to enhance global food security. By working on new approaches to improve fundamental elements of plant photosynthetic efficiency and optimizing carbon metabolism to direct more carbon to seed production, the Company is advancing several yield traits it has developed in crops, such as Camelina, canola, soybean and corn. The Company concentrates on technologies that enables it to improve carbon dioxide fixation efficiency in photosynthesis and its direction to and conversion into plant matter. The Company has an additional agricultural science facility with greenhouses in Saskatoon, Saskatchewan, Canada. YIELD10 BIOSCIENCE, INC. (NASDAQ:YTEN) Recent Trading Information
YIELD10 BIOSCIENCE, INC. (NASDAQ:YTEN) closed its last trading session down -0.011 at 0.358 with 9,573 shares trading hands.